US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 40.720
  • +0.335+0.83%
Close Dec 20 16:00 ET
  • 41.000
  • +0.280+0.69%
Post 19:56 ET
3.48BMarket Cap-14.59P/E (TTM)

CRISPR Therapeutics Key Stats

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.598M--
--2024/Q4-- / 7.768M--
--2024/Q3602.000K / 7.132M--
--2024/Q2517.000K / 13.613M--
--2024/Q1504.000K / 26.494M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 11.598M--
--2024/Q4-- / 7.768M--
--2024/Q3602.000K / 7.132M--
--2024/Q2517.000K / 13.613M--
--2024/Q1504.000K / 26.494M--

Unlock Free Earnings Estimates

CRISPR Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 19, 2024

Buy

  • Buy

    52.63%
  • Hold

    36.84%
  • Sell

    10.53%

Price Target

No Data